SLTM anticorps (AA 551-650) (Cy5)
Aperçu rapide pour SLTM anticorps (AA 551-650) (Cy5) (ABIN915675)
Antigène
Voir toutes SLTM AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 551-650
-
Homologie
- Human,Mouse,Rat,Dog,Cow,Sheep,Horse
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human SLTM
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- SLTM (SAFB-Like, Transcription Modulator (SLTM))
-
Autre désignation
- SLTM
-
Sujet
-
Synonyms: DKFZp762G052, FLJ10005, FLJ13213, MET, Modulator of estrogen induced transcription, SAFB like transcription modulator, SLTM_HUMAN.
Background: When SLTM is overexpressed it acts as a general inhibitor of transcription that eventually leads to apoptosis.
-
ID gène
- 79811
Antigène
-